文献速递生殖医学

对卵巢储备功能减退不孕女性行新鲜卵巢皮质组织活检、碎片化及自体移植

Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve.
PubMed 文献 · Hum Reprod · 2019-01-01

前瞻性临床队列研究纳入20例卵巢储备功能减退(DOR)不孕女性,随机选择一侧卵巢行4处活检、皮质组织碎片化后自体移植至腹膜囊袋,对侧卵巢为对照。术后10周可募集卵泡数在活检侧与对照侧无显著差异(1.0 vs 0.7,P=0.35),但12/20(60%)患者在1年随访内获得临床妊娠。

要点

  • 卵巢活检联合碎片化皮质组织自体移植未增加术后10周可募集卵泡数。
  • 仅3例患者在移植部位检测到4个卵泡生长,其中1枚MII卵子受精后胚胎发育失败。
  • 12/20(60%)患者随访期间获得临床妊娠,每启动IVF/ICSI周期累积活产率18.4%。

核心结论

  • 卵巢活检、碎片化及自体移植未增加DOR女性术后10周IVF/ICSI可募集卵泡数。
  • 部分患者可能在术后5-8周出现卵泡反应。
  • 作者认为未来可开展研究探讨活检本身的作用,并将IVF/ICSI刺激提前至第10周之前。

研究设计与样本

  • 前瞻性临床队列研究,纳入2016年4月至2017年12月在丹麦Rigshospitalet生育门诊治疗的20例DOR女性。
  • 患者随机选择左侧或右侧卵巢行腹腔镜下4处活检,皮质组织碎片化至约1 mm³后自体移植至腹膜囊袋,对侧卵巢为对照。
  • 非妊娠患者平均随访280天(范围118-408天),妊娠者随访至分娩,非妊娠患者随访于2018年9月结束。

主要发现

  • 术后10周卵巢刺激后成熟卵泡数活检侧 vs 对照侧为1.0 vs 0.7个(P=0.35)。
  • 仅3例患者在术后24-268天于移植部位检测到4个卵泡生长,其中1枚MII卵子受精后胚胎发育失败。
  • 总体AMH水平术后无显著变化(P=0.2);AFC每周增加0.14(95%CI 0.06;0.21,P<0.005),活检侧卵巢平均比对照侧少0.6个卵泡(95%CI 0.3;-0.88,P=0.01)。
  • 术后1周雄烯二酮和睾酮分别显著升高0.63 nmol/L(95%CI 0.21;1.04)和0.11 nmol/L(95%CI 0.01;0.21),睾酮在10周内每周递增0.0095 nmol/L(95%CI 0.0002;0.0188,P=0.045)。
  • 7/20例患者术后5-8周出现血清AMH升高,该组平均AMH从第1-4周的2.08 pmol/L(范围1.74-2.34)升至第5-8周的3.94 pmol/L(范围3.66-4.29)。

临床怎么用

  • 当前研究未表明活检、碎片化及自体移植能增加术后10周IVF/ICSI可募集卵泡数。
  • 作者认为未来可开展研究探讨活检本身的作用,并将IVF/ICSI刺激提前至第10周之前。

局限性

  • 纳入患者数量有限。
  • 缺乏未手术对照组。
  • 20例中9例入组时无男性伴侣并接受供精治疗,但每例入组前平均已有6.8次(范围4-9)供精医学辅助生殖治疗失败。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can ovarian biopsying per se and/or autotransplantation of fragmented ovarian cortical tissue activate dormant follicles and increase the number of recruitable follicles for IVF/ICSI in women with diminished ovarian reserve (DOR)? SUMMARY ANSWER: Ovarian biopsying followed by immediate autotransplantation of fragmented cortical tissue failed to increase the number of recruitable follicles for IVF/ICSI 10 weeks after the procedure either at the graft site or in the biopsied ovary, but 12 of the 20 women subsequently had a clinical pregnancy during the 1-year follow-up. WHAT IS KNOWN ALREADY: Infertile women with DOR constitute a group of patients with poor reproductive outcome mainly due to the low number of mature oocytes available for IVF/ICSI. Recent studies have shown that in vitro activation of residual dormant follicles by both chemical treatment and tissue fragmentation has resulted in return of menstrual cycles and pregnancies in a fraction of amenorrhoeic women with premature ovarian insufficiency. STUDY DESIGN, SIZE, DURATION: This is a prospective clinical cohort study including 20 women with DOR treated at the fertility clinic, Rigshospitalet, Denmark, during April 2016-December 2017. Non-pregnant patients were on average followed for 280 days (range 118-408), while women who conceived were followed until delivery. Study follow-up of non-pregnant patients ended in September 2018. PARTICIPANTS, MATERIALS, SETTING, METHODS: The study included infertile women aged 30-39 years with preserved menstrual cycles, indication for IVF/ICSI and repeated serum measurements of anti-Müllerian hormone (AMH) ≤ 5 pmol/L. Patients were randomized to have four biopsies taken from either the left or the right ovary by laparoscopy followed by fragmentation of the cortical tissue to an approximate size of 1 mm3 and autotransplanted to a peritoneal pocket. The other ovary served as a control. Patients were followed weekly for 10 weeks with recording of hormone profile, antral follicle count (AFC), ovarian volume and assessment for ectopic follicle growth. After 10 weeks, an IVF/ICSI-cycle with maximal ovarian stimulation was initiated. MAIN RESULTS AND THE ROLE OF CHANCE: No difference in the number of mature follicles after ovarian stimulation 10 weeks after the procedure in the biopsied versus the control ovaries was observed (1.0 vs. 0.7 follicles, P = 0.35). In only three patients, growth of four follicles was detected at the graft site 24-268 days after the procedure. From one of these follicles, a metaphase II (MII) oocyte was retrieved and fertilized, but embryonic development failed. Overall AMH levels did not change significantly after the procedure (P = 0.2). The AFC increased by 0.14 (95% CI: 0.06;0.21) per week (P < 0.005), and the biopsied ovary had on average 0.6 (95% CI: 0.3;-0.88) follicles fewer than the control ovary (P = 0.01). Serum levels of androstenedione and testosterone increased significantly by 0.63 nmol/L (95% CI: 0.21;1.04) and 0.11 nmol/L (95% CI: 0.01;0.21) 1 week after the procedure, respectively, and testosterone increased consecutively over the 10 weeks by 0.0095 nmol/L (95% CI: 0.0002;0.0188) per week (P = 0.045). In 7 of the 20 patients, there was a serum AMH elevation 5 to 8 weeks after the procedure. In this group, mean AMH increased from 2.08 pmol/L (range 1.74-2.34) to 3.94 pmol/L (range 3.66-4.29) from Weeks 1-4 to Weeks 5-8. A clinical pregnancy was obtained in 12 of the 20 (60%) patients with and without medically assisted reproduction (MAR) treatments. We report a cumulated live birth rate per started IVF/ICSI cycle of 18.4%. LIMITATIONS, REASON FOR CAUTION: Limitations of the study were the number of patients included and the lack of a non-operated control group. Moreover, 9 of the 20 women had no male partner at inclusion and were treated with donor sperm, but each of these women had an average of 6.8 (range 4-9) unsuccessful MAR treatments with donor sperm prior to inclusion. WIDER IMPLICATIONS OF THE FINDINGS: Although 12 out of 20 patients became pregnant during the follow-up period, the current study does not indicate that biopsying, fragmenting and autotransplanting of ovarian cortical tissue increase the number of recruitable follicles for IVF/ICSI after 10 weeks. However, a proportion of the patients may have a follicular response in Weeks 5-8 after the procedure. It could therefore be relevant to perform a future study on the possible effects of biopsying per se that includes stimulation for IVF/ICSI earlier than week 10. STUDY FUNDING/COMPETING INTEREST(S): This study is part of the ReproUnion collaborative study, co-financed by the European Union, Interreg V ÖKS. The funders had no role in the study design, data collection and interpretation, or decision to submit the work for publication. None of the authors have a conflict of interest. TRIAL REGISTRATION NUMBER: NCT02792569.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lunding SA, Pors SE, Kristensen SG, et al. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve. Hum Reprod. 2019. PMID: 31593582. doi:10.1093/humrep/dez152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。